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The inability to maintain the immaturity of stem cell populations in vitro restricts the long-term expansion of various
types of human epithelial stem cells. However, recent technical advances in epithelial stem cell culture have led to the
development of novel in vitro strategies for regenerating epithelial tissues and for closely mimicking human diseases
such as cancer and inflammation. Specifically, improvements in culture conditions provided by small molecules in
combination with three-dimensional (3D) culture approaches have facilitated the establishment of in vitro systems that
recapitulate biological properties in epithelial organs, and these systems may be used to model disease. In this review
article, we describe the biological significance of technical improvements in the development of these methods,
focusing on human epithelial cells, including stratified and columnar epithelial cells. We also discuss the potential and
future perspectives of this technology, which is only beginning to be explored.
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The isolation and long-term expansion of primary cells,
particularly stem/progenitor populations, are fundamental
and important basic techniques in various biological fields,
including developmental biology and stem cell biology,
and medical science. Cells in stratified and columnar
epithelial tissues are highly regenerative and disproportion-
ately accountable for many human cancers; however, clon-
ing adult stem cells is limited by difficulties in maintaining
these cells in an immature state. In recent years, technical
innovations have resulted in rapid and dramatic progress
in stem cell biology, such as the use of small molecules and
growth factors to mimic tissue niche environments and
facilitating “Organoid culture” [1].
In 1975, Rheinwald and Green established the first
successful example of human adult stem cell culture using
human keratinocytes [2]. Specifically, they maintained
human keratinocytes long-term in combination with a
sublethally irradiated mouse fibroblast cell line, 3T3-J2.
Although they did not use the term “stem cells” for cloned
keratinocytes grown on 3T3 cells, Green and colleagues* Correspondence: yuyamamo@ncc.go.jp
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form new colonies after passage, which they termed
“Holoclones” [3]. These holoclones consists of small,
immature cells that all exhibited intense nuclear staining
with p63, a master regulator of stemness, in stratified
epithelial cells [4]. In the stratified epithelium, including
skin, lung bronchia, mammary gland, and bladder urothe-
lium, the stem cell population was mainly localized in the
basal layer, and immature cells were stained with p63,
consistent with the in vitro studies [5]. Significantly,
isolated and expanded human keratinocytes from autolo-
gous skin have been successfully grafted to burn patients
and regenerated a permanent epidermis resembling that
result from split-thickness skin grafts [6, 7]. Notably, the
same procedure has been applied to isolate and expand
human corneal epithelial cells for transplantation [8–10].
Although this technology was limited to stem cells in the
epidermis and cornea at that time, Green and colleagues
created the foundation for cloning human adult stem cells
in the fields of basic biology and regenerative medicine.
In this review article, we provide an overview of recent
research progress and accumulating evidence of a cell
culture system that has led to technical breakthroughs in
epithelial cell technologies. Novel culture strategies forle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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cells have enabled human epithelial development to be
recapitulated and can be used to generate a human
disease model in vitro. We also discuss the potential and
possible applications of normal epithelial cell culture
technologies for regenerative medicine and highlight a
cancer cell culture system that reproduces individual
patient phenotypes.
Stratified epithelial cell culture
In stratified epithelial tissues, including glandular and
pseudostratified epithelium, p63+ cells, which are local-
ized on the basement membrane, can self-renew to
maintain stem/progenitor populations and give rise to
progeny that form functional tissues [4, 5]. As men-
tioned above, the cloning and expansion of epithelial
stem cells, such as skin keratinocytes and corneal epithe-
lial cells, have been well-established in co-culture
systems with irradiated mouse 3T3-J2 fibroblasts. How-
ever, this standard protocol has largely been limited to
the long-term culture of keratinocytes and corneal cells.
Nevertheless, cloned stem cells from thymic epithelia
have been reported, as has the isolation of thymic
epithelial stem cells from diverse species, including hu-
man cells, cultured with a 3T3 feeder system [4, 11, 12].
Furthermore, Frey and colleagues recently applied the
3T3 feeder method to isolate urothelial stem cells that
expressed sonic hedgehog and resided in the basal layer
of the bladder urothelium [13]. These urothelial stemStratified epithelial stem cells
(e.g. skin, airway, mammary glan
Columnar epithelial stem cells
(e.g. intestine, stomach, oviduct)
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Fig. 1 Schematic of the cell culture process for human stratified and colum
epithelial stem cells, they are isolated from biopsy or surgical specimens ar
stem cells, they are plated on a 3T3 layer with defined factors which ar
immature colonies (packed colonies with small cells) of epithelial stem c
In the ALI culture, the cells undergo differentiation into mature cell typecells from isolated human and porcine tissue were stably
grown on a 3T3 feeder layer and were able to give rise
to multiple cell lineages, including p63+ basal cells and
Uroplakin 2+ and 3+ urothelial cells, after renal capsule
transplantation in nude mice. In 2011, Pooja et al.
exploited the 3T3 culture system to isolate three types of
human airway epithelial stem cells, i.e., nasal, tracheal
and distal airway stem cells, and found that these airway
epithelial stem cells exhibited distinct cellular pheno-
types after in vitro differentiation, although the imma-
ture stem cell clones appeared to be morphologically
indistinguishable (Fig. 1) [14]. In a follow-up study, the
transplantation of mouse tracheal and distal airway
epithelial stem cells demonstrated that distal airway
stem cells were readily incorporated into H1N1
influenza-damaged lung tissue and differentiated into
multiple epithelial cell types, i.e., bronchioles and alveoli,
whereas transplanted tracheal stem cells were localized
only in major airways [15]. Clonogenic stem cells were
also isolated from human esophagus endoscopic biopsy
samples, and these cells were able to form well differen-
tiated, stratified squamous epithelia-like structures in an
air liquid interface (ALI) culture system [16].
Schlegel and colleagues reported that a Rho-associated
protein kinase (ROCK) inhibitor in combination with 3T3
feeder cells significantly increased the proliferative
capacity of epithelial stem cells, including human kerati-
nocytes, prostate cells, and mammary gland cells, and they
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cell cultures from patients provides critical and valuable
insights into cell-based diagnostics and therapeutics [19].
More recently, Rajagopal and colleagues showed that the
TGFβ/BMP/SMAD signaling pathway is important in
various epithelial tissues, including ectoderm-derived skin
and mammary gland tissue, endoderm-derived esophagus
and prostate tissue, and mesoderm-derived epididymis.
They discovered that the dual inhibition of SMAD signal-
ing (the BMP signal was blocked by DMH-1 and the
TGFβ signal was inhibited by A-83-01) facilitated the
stable propagation of human and mouse epithelial basal
cell populations. Surprisingly, dual TGFβ/BMP inhibition
enabled the robust expansion of epithelial stem cells with-
out the need for mouse 3T3 feeder cells.
Collectively, these technical advances, in combination
with small molecules and feeder cells, can be used to
continuously and efficiently expand stratified epithelial
stem/progenitor populations in vitro. Another break-
through in stratified epithelial culture, organoid culture,
has been utilized to expand both basal and luminal human
prostate progenitors. These human luminal progenitors
were multipotent and formed prostate gland-like struc-
tures in vitro [20]. However, generating three-dimensional
structures consisting of stratified or pseudostratified
epithelia to recapitulate authentic in vivo architecture
remains challenging, although many researchers have
reported spheroid and organoid cultures. This problem
may be solved by establishing a method to facilitate self-
organization, as performed in pluripotent stem cell-
derived tissues [21, 22].
Columnar epithelial cell culture
Although intestinal stem cells possess the remarkable
capacity to proliferate at a high turnover rate to main-
tain intestinal epithelia, and hepatocytes are highly
regenerative in response to damage, the ability to clone
stem cell populations from columnar epithelial cells is
severely limited, presumably due to a lack of tissue niche
signals in vitro. Over the past decade, Clevers and col-
leagues discovered LGR5 (leucine-rich repeat-containing
G-protein coupled receptor 5), an intestinal stem cell
marker, in a sophisticated mouse model (Lgr5-EGFP-
ires-CreERT2 mice crossed with the Cre-activated
Rosa26 LacZ reporter) and established a mouse intes-
tinal organoid culture method that consists of villus-like
structures and crypt-like zones with multiple intestinal
cell types [23]. In combination with growth factors and
small-molecule cocktails, an isolated LGR5+ stem cell
fraction was suspended in Matrigel and cultured long-
term [24]. Modifying the culture condition with the use
of nicotinamide, a p38 and TGFβ receptor inhibitor,
human epithelial cells isolated from the small intestine
and colon were able to infinitely expand long-termin vitro [25, 26]. This technique is applicable to culture
other types of cells, such as pancreatic duct cells [27]
and hepatocytes [28], and facilitated revolutionary
advances in columnar epithelial cell culture.
Organoid culture employs a Matrigel-based 3D culture
platform and can be extensively used to stably culture
diverse types of adult epithelial cells, including stratified
epithelial cells, with stem/progenitor cell populations
[1]. However, the ability to rapidly and efficiently propa-
gate a fraction of uniform stem cells in vitro is also use-
ful and important for the detailed study of self-renewal
and fate specification in tissue stem cells and possible
future applications of cell transplantation for regenera-
tive medicine. Xian and colleagues recently developed a
novel culture system for the homogeneous expansion of
human fetal intestinal stem cells, including small intes-
tine and colon cells. This system employed a 3T3 mouse
feeder layer in combination with growth factors and
signal pathway inhibitors to robustly expand human
columnar epithelial stem cells (Fig. 1) [29, 30]. Moreover,
more than 50% of intestinal stem cells grown on 3T3
fibroblasts were able to form colonies. In the mamma-
lian intestine, defined niche factors, such as Wnt and
Notch signals, are essential for governing the stemness
of intestinal stem cells at the crypt base. Furthermore,
Paneth cells, which are also located at the crypt base,
arise from stem cells and act as the stem cell niche by
providing essential factors in a paracrine manner. Be-
cause organoid cultures consist of stem cells and various
derivatives, such as Paneth cells, niche factors are au-
tonomously supplied [31]. By contrast, because a pure
population of intestinal stem cells is grown on a 3T3
feeder layer, the cells cannot secrete niche factors.
Therefore, extrinsic factors resembling niche factors
need to be supplemented. In addition to the stem cell
maintenance protocol, a differentiation protocol has
been established in an ALI culture model to give rise to
at least four types of major intestinal cells, i.e., Paneth
cells, entero-endocrine cells, goblet cells, and entero-
cytes (intestinal absorptive cells) [29]. The formation of
intestinal villus-like structures was observed according
to the original tissue types, such small intestine and
colon tissues (Fig. 1). In a different ALI culture
approach, Kuo and colleagues robustly cultured small
pieces of mouse neonatal intestine with a stromal elem-
ent long-term [32].
The same strategy was also applied to clone human
gastric stem cells obtained from endoscopic biopsy.
Specifically, clonogenic gastric cells were stably ex-
panded on a 3T3 feeder layer in combination with
growth factors and small molecules and differentiated
into gastric epithelial lineages typically found in the
stomach, such as pepsinogen-expressing chief cells [16].
In addition to cloned digestive organ stem cells, oviduct
Yamamoto and Ochiya Inflammation and Regeneration  (2017) 37:3 Page 4 of 7progenitor cells from the distal uterus tube were also
able to infinitely propagate on a 3T3 feeder layer in the
presence of niche factors [33]. The distal oviduct,
fimbria epithelium, is a simple columnar epithelium
layer that consists of the following two types of cells:
ciliated cells, which enhance the transport of gametes,
and secretory cells, which secrete mucus. Using a slight
modification of the differentiation protocol for intestinal
stem cells, long-term ALI-cultured oviductal stem cells
gave rise to a 3D architecture, containing both ciliated
and secretory cells, that was reminiscent of the in vivo
epithelium structure [34]. The ability to produce epithe-
lial lineages with proper cell types from a stem cell
population could be a useful tool to study physiological
epithelial development and homeostasis and develop
acute and chronic disease models in vitro.
Cancer cell culture
Since the first cancer cell line, the HeLa cell line, was
established from a cervical cancer patient in 1951 [35],
cancer cell lines established from a wide variety of cancer
types have been widely used to study the pathobiology of
cancer and provided opportunities to generate in vivo
xenograft models and test anti-cancer drugs in vitro and
in vivo. Although tremendous advances have been made
in cancer biology using cancer cell lines, the results
obtained using these cells may not sufficiently reflect the
complexity of the disease as originally expected because
cancer exhibits interpatient and intratumor heterogeneity,
as revealed by recent advances in next-generation sequen-
cing [36]. To more precisely reflect cancer phenotypes,
including the patient’s gene mutation status and path-
ology, Welm and colleagues developed patient-derived
xenograft (PDX) models of breast cancer in nonobese
diabetic severe combined immunodeficiency (NOD-SCID)
mice that maintained the essential features of the original
tumors and exhibited metastatic capacity to specific sites
[37]. In addition to the breast cancer model, the establish-
ment of various types of solid tumors demonstrated the
feasibility of PDX models [38], which are anticipated to
accelerate the preclinical testing of new cancer therapies
and help realize the goal of “personalized medicine”.
Culture methods for adult stem cells, such as organoid
and feeder systems, are also applicable to different
approaches that use patient-derived cancer cells. Specif-
ically, Clevers and colleagues reported that organoid
culture can be used to model pancreas [39], prostate
[40], and colorectal cancer [41] and showed that the
original cancer traits, including genetic heterogeneity
and drug sensitivity, can be recapitulated. Therefore, they
termed this system a “living organoid biobank”. These tech-
nologies could also be used to isolate a stem cell population
from a precancerous lesion, such as Barrett’s esophagus, a
precursor of human esophageal adenocarcinoma [16, 25].Isolated and expanded Barrett’s esophagus stem cells were
transformed by introducing SV40 large T antigen, hTERT,
and c-myc and xenografted into immunocompromised
NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) mice [16]. As
expected, Barrett’s esophagus stem cells transformed into
esophageal adenocarcinoma-like tumors in mice. A similar
approach demonstrated that human oviductal stem cells
were the cell of origin in high-grade serous ovarian epithe-
lial cancer [34]. This finding corroborates recent human
pathology and the transgenic mouse model evidence, which
indicated that the distal oviductal epithelium is the tissue of
origin for this cancer [42, 43]. In combination with the
CRISPR/Cas9 system, normal colon stem cells were se-
quentially transformed by introducing the driver mutations
that are frequently detected in colorectal cancer [44, 45].
The resultant cells were allowed to form xenografts in the
kidney capsule and exhibited progressive transformation
into adenocarcinoma-like phenotypes characterized by
invasive and metastatic properties. Overall, the ability to
isolate and culture cells from tumor- and patient-matched
normal epithelial tissues facilitates the production of a
platform that not only complements classic in vivo animal
work in the field of cancer biology but also facilitates
patient-specific genetics and genomics approaches in vitro.
Modeling inflammation disease with adult stem cells
Modeling human disease is hindered by the limited
accessibility of human diseased tissues. Nevertheless,
advances in adult stem cell cultivation have allowed us
to reproduce disease phenotypes in vitro by expanding
stem cells and deriving mature cell types from small
human biopsy samples. Because 3D culture methods,
such as ALI and organoid culture, provide structures
that consist of multiple cell types and resemble the
epithelium architecture observed in vivo, they should be
suitable for studying inflammatory diseases, including
infectious and hereditary diseases. Specifically, reprodu-
cing the disease phenotype is simple when the pathogen
(or main cause) and targeted cell type are known.
Pseudomembranous colitis (PMC) is caused by a dispro-
portionally increased population of Clostridium difficile
(C. difficile) after antibiotics treatment. C. difficile is a
Gram-positive, spore-forming bacterium, and produces
the high-molecular-weight toxins TcdA and TcdB, which
induce fluid secretion, inflammation, and colonic tissue
damage. Colonic epithelial cells differentiated from clono-
genic colonic stem cells in ALI culture were challenged
with these toxins, which caused devastating epithelial
damage in a time- and dose-dependent manner. This
result indicated that the 3D culture model may be used to
represent C. difficile pathology [29]. Similarly, the effect of
Helicobacter pylori (H. pylori) infection, which causes
chronic gastritis, gastric ulcers and cancer, was studied by
microinjecting H. pylori into organoid cultures. Bacteria-
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tion, such as NF-kB activation and IL8 induction, and IL8
expression was significantly higher in gland-type organoid
cultures than in pit-type organoid cultures [46].
Adult stem cells have also been used to model hereditary
disease. Beekman and colleagues reported an intestinal
organoid culture derived from cystic fibrosis (CF) patients.
CF is caused by mutations in the cystic fibrosis transmem-
brane conductance regulator (CFTR), which is normally
expressed in the epithelial cells of many organs, such as
lung and digestive tissues. Although normal intestinal orga-
noid cultures exhibited robust swelling in response to
Forskolin, the swelling response was not observed in CF
organoid cultures [47]. Moreover, when the mutated CFTR
locus was corrected using the CRISPR/Cas9 technology in
intestinal organoids of CF patients, the corrected genes
were shown to functionally work [48]. Therefore, in vitro
differentiation of adult stem cells, resembling in vivo
phenotypes with multiple cell types in combination with
gene editing technologies, provides powerful means for
treating human disease and may provide direct insight into
human pathology.
Application of epithelial stem cells for regenerative
medicine
Despite promising strategies that use human embryonic
stem (ES) cells and induced pluripotent stem (iPS) cells
for applications in regenerative medicine, few clinical tri-
als of these strategies are ongoing, which is in part due
to difficulties in lineage specification and the possibility
of tumorigenesis. Because adult stem cells are essentially
committed to specific tissue types, producing intended
cell types is relatively easy, and the potential risk for
tumorigenesis is low. Thus, therapeutic approaches are
aiming to use adult stem cells as the cell source for
transplantation. Although Green and colleagues estab-
lished the human keratinocyte culture method in 1975
and the cultured cells were transplantable into patients
with burns or chemical injuries, the long-term cultiva-
tion of other types of adult stem cells was subject to
significant technical barriers. As described above, recent
technical advances overcame this limitation for diverse
types of epithelial cells. Hence, the ability to rapidly and
efficiently expand stem cell populations is valuable for
their use in regenerative medicine.
For example, mouse Lgr5+ colonic stem cells have
been expanded in organoid culture and transplanted into
the damaged mouse colon, and engrafted cells that were
able to self-renew and differentiated were detected even
after 25 weeks [49]. In a different approach, Zhang K
and colleagues harnessed engineered adult stem cells for
a transplantation study. First, they successfully cultured
corneal epithelial cells in a dish without feeder cells and
then found that Pax6 is a key transcription factor thatdifferentiates corneal stem cells (CSCs) from skin kerati-
nocytes. Surprisingly, Pax6-overexpression in keratino-
cytes induced limbal stem cell-like cells, and these cells
could be transplanted into the injured corneas of rabbits
[50]. Because keratinocytes are more readily accessible
than CSCs, this method may be applicable for the treat-
ment of human eye disease. More recently, Liu et al.
reported an attractive approach for tissue repair and
regeneration that used endogenous stem cells. In their
study, lens epithelial stem cells (LECs) that expressed
Pax6 and Bmi1 were characterized and exhibited regen-
erative potential in vivo. A surgical cataract removal
method that preserves endogenous LECs was employed,
and these LECs contributed to the spontaneous regener-
ation of lenses with visual function in rabbits, macaques,
and human infants. This method could be a therapeutic
breakthrough for cataract treatment and potentially
replace artificial intraocular lens implantation [51].
Because of the high turnover rates of many epithelial
cells, transplanting stem cell populations is essential for
long-term tissue maintenance. Theoretically, a single
stem cell can reconstitute whole tissues, and several
research groups empirically demonstrated this notion
[52, 53]. Despite the potential of pluripotent stem cells
(PSCs), which can give rise to all cell types, PSC-derived
tissue stem cells likely cannot be maintained in the
immature state in vitro. Therefore, the use of adult stem
cells for regenerative medicine presents a significant
advantage.
Conclusions
In recent years, remarkable progress has been made in
the development of in vitro culture system for epithelial
stem cells. The realization of the long-term culture of
epithelial stem cells allows us not only to reproduce
physiological events in vitro but also enables the devel-
opment of therapeutic platforms based on cell trans-
plantation. An increasing number of studies of epithelial
stem cells clearly indicated that understanding the basic
biology of these cells will be closely linked with clinical
studies of human disease pathology, such as cancer and
inflammation. The interactions of biological networks
during tissue development and disease progression are
complex at the cellular and molecular levels. Building an
in vitro epithelial structure model can simplify this com-
plexity and provide comprehensive views of epithelial
physiology and pathophysiology. Moreover, in vitro
epithelial models can easily be combined with genomic
and epigenetic approaches and single-cell analyses. In
addition, genome editing, e.g., the CRISPR-Cas9 system,
can also be readily incorporated into the model. One
drawback of in vitro epithelial structure models derived
from the stem cells is that epithelial structures lack stro-
mal populations. Although a simplified system provides
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the interaction between different cell types is important
for reproducing a genuine phenotype because all tissues
consist of multiple cell types, such as epithelial cells,
endothelial cells, mesothelial cells, fibroblasts, and
hematopoietic cells. One possible solution to this prob-
lem is a self-organizing method, in which several cell
types are mixed in vitro and spontaneously form actual
organ-like structures. Although improvements are
required to recapitulate the in vivo behavior of human
organs, the ability to expand epithelial stem cells and
generate a 3D structure model holds great promise for
both basic and clinical research.
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